🇺🇸 FDA
Pipeline program

CB-010

CB10A

Phase 1 gene_therapy active

Quick answer

CB-010 for Lymphoma, Non-Hodgkin is a Phase 1 program (gene_therapy) at Caribou Biosciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Caribou Biosciences
Indication
Lymphoma, Non-Hodgkin
Phase
Phase 1
Modality
gene_therapy
Status
active

Clinical trials